Mayo Clinic news briefs

March 13, 2002

ROCHESTER, MINN. -- A Mayo Clinic study analyzing coronary calcium and plaque found that estrogen may slow the progression of atherosclerosis in women.

Estrogen status is associated with coronary calcium ("hardening of the arteries") and plaque area independent of age and coronary heart disease risk factors, the researchers reported. Estrogen may modulate the calcium content of atherosclerotic plaques, as well as plaque area and may slow the progression of atherosclerosis in women.

The study appears in the March 4 issue of the Journal of Endocrinology and Metabolism.

Observational studies suggest that postmenopausal women treated with estrogen replacement therapy have a significantly reduced risk of coronary heart disease and less extensive coronary calcification than untreated women. However, the role of estrogen in the primary and secondary prevention of coronary heart disease remains controversial as its cardioprotective effects have not been confirmed in prospective clinical trials in women with established heart disease.

"We still don't know if estrogen is beneficial against heart disease, but this study suggests it might slow the progression of atherosclerosis in women," said Lorraine Fitzpatrick, M.D., a Mayo Clinic endocrinologist and the principal investigator of the study.

"Our data indicate a strong negative association between estrogen status and both coronary calcium and plaque, and suggest that coronary calcification and plaque formation may progress at different rates in the presence of estrogen," Dr. Fitzpatrick said. "In light of the recent controversies related to findings of estrogen replacement therapy in prospective clinical trials, understanding the role of estrogen in the pathogenesis of the calcified, atherosclerotic plaque has become increasingly relevant."

In the study, coronary arteries were obtained at autopsy from 56 white women age 18-98 years, 46 postmenopausal and 10 premenopausal. They were excluded if they had coronary stents, coronary artery bypass surgery, or were a medical-legal case. Medical records were reviewed for demographics, coronary heart disease risk factors, menstrual status, and use of estrogen replacement therapy.
-end-
Contact:
Sara Bakken
507-284-5005 (days)
507-284-2511 (evenings)
email: newsbureau@mayo.edu

Mayo Clinic

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.